Abatacept

Details

Files

Generic Name:

Abatacept

Project Status:

Complete

Therapeutic Area:

Arthritis, rheumatoid

Manufacturer:

Bristol-Myers Squibb Canada

Call for patient/clinician input open:

November 23, 2012

Brand Name:

Orencia

Project Line:

Reimbursement Review

Project Number:

SR0299-000

Call for patient/clinician input closed:

December 21, 2012

NOC Status at Filing:

Pre NOC

Submission Type:

Initial

Indications:

Arthritis, Rheumatoid

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

July 18, 2013

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : November 29, 2012